Status:

COMPLETED

Transcranial Direct Current Stimulation Therapy for Bipolar Depression

Lead Sponsor:

University of East London

Collaborating Sponsors:

University College, London

King's College London

Conditions:

Depression, Bipolar

Bipolar Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Bipolar disorder is a severe and disabling disorder. The course of illness is often progressive but is highly heterogeneous between individuals and within the lifetime for an individual. The most comm...

Detailed Description

The novel brain stimulation treatment, transcranial direct current stimulation (tDCS), is a potential first-line treatment for bipolar disorder. tDCS generates a small electric current which modulates...

Eligibility Criteria

Inclusion

  • diagnosis of bipolar disorder based on DSM-5 criteria
  • minimum score of 18 on the MADRS
  • being on a stable dosage of mood stabilizing medication for a minimum of two weeks

Exclusion

  • comorbid psychiatric disorder
  • significant risk of suicide or self harm
  • any contraindications to tDCS, including implanted electronic medical devices
  • history of epilepsy

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 30 2024

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT05436613

Start Date

May 1 2022

End Date

May 30 2024

Last Update

August 14 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of East London

London, United Kingdom, E16 2RD